Pharmall
Company Profile
Services
Partners
News
Contact Us

Pharmaceuticals and medical devices

FULLFILMENT OF TARGET EXPANSION

IN SYRIA, SUDAN, KENYA

AND TANZANIA

Exclusivity of Products


Partners - Products

The excellent organisational infrastructure of Pharmall EEBE ensures reliability, which is an essential element of successful strategic partnerships and long-term cooperations. Successful collaboration with major pharmaceutical companies is based on agreements that are divided into:

Business Development: Launching products from the EU and Australia

to Asia and now successfully entering Africa.

Further growth strategies such as the Market Development (new markets, existing products) are used. Pharmall has already created solid ground for entering the markets of Sudan and Libya.

Pharmall EEBE has focused on organised market segmentation policies in order to clarify its market orientation. Pharmall has successfully organised its market segmentation by conducting a market analysis on how to offer B2B services. Concentrating on the evaluation and re-planning of history based data and market knowledge regarding tangible and intangible attributes (benefits, features, functions) has contributed to the company’s successful market segmentation.

The extracted benefits are multiple. They have even created the suitable conditions to develop the Market Penetration Strategy by organising workshops, addressing more medical representatives to provide customers with direct information concerning the best quality medicines offered by our partners and by controlling and expanding an excellent distribution network.

 

 

 

________________________________________________________________

PHARMALL E.E.B.E. Pharmaceuticals & Medical Devices

 

Promoting with Responsibility

Our strategy is based on carefully planned moves and accurate alternatives in order to achieve a steady route for our partners. Our aim is to be more flexible while keeping solid values and to make our services better and faster by specialising in all export procedures (licensing, product registration, issuing of performance bonds).The competitive advantage derives from strong bonds that have been developed recently and a complete network of long-term partners.

>> Read More...